Increased numbers of gastric-infiltrating mast cells and regulatory T cells are associated with tumor stage in gastric adenocarcinoma patients

Oncology Letters

Volumn 4, Issue 4, 2012, Pages 755-758

  Zhao, Yibin ^a   Wu, Ke ^a   Cai, Kailin ^a   Zhai, Ronglin ^a   Tao, Kaixiong ^a   Wang, Guobin ^a   Wang, Jiliang ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Coexpression; Gastric cancer; Mast cells; Regulatory T cells; TNM stage

Indexed keywords

TRANSCRIPTION FACTOR FOXP3; TRYPTASE;

ADULT; AGED; ARTICLE; CANCER INFILTRATION; CANCER PATIENT; CANCER PROGNOSIS; CANCER STAGING; CELL INFILTRATION; CELL ISOLATION; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN TISSUE; LEUKOCYTE; MAJOR CLINICAL STUDY; MALE; MAST CELL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; RISK; STOMACH ADENOCARCINOMA;

EID: 84864646479     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2012.830     Document Type: Article

References (34)

1. Murray CJ and Lopez AD: Mortality by cause for eight regions of the world: Global Burden of Disease Study. Lancet 349: 1269-1276, 1997.
2. Jemal A, Siegel R, Ward E, Hao Y, Xu J and Thun MJ: Cancer statistics, 2009. CA Cancer J Clin 59: 225-249, 2009.
3. Crew KD and Neugut AI: Epidemiology of gastric cancer. World J Gastroenterol 12: 354-362, 2006.
4. Parkin DM, Bray F, Ferlay J and Pisani P: Global cancer statistics, 2002. CA Cancer J Clin 55: 74-108, 2005.
5. Dougan M and Dranoff G: Immune therapy for cancer. Annu Rev Immunol 27: 83-117, 2009.
6. Rabinovich GA, Gabrilovich D and Sotomayor EM: Immunosuppressive strategies that are mediated by tumor cells. Annu Rev Immunol 25: 267-296, 2007.
7. Beyer M and Schultze JL: Regulatory T cells in cancer. Blood 108: 804-811, 2006.
8. Fontenot JD, Gavin MA and Rudensky AY: Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol 4: 330-336, 2003.
9. Kryczek I, Liu R, Wang G, Wu K, Shu X, et al: FOXP3 defines regulatory T cells in human tumor and autoimmune disease. Cancer Res 69: 3995-4000, 2009.
10. Khazaie K, Blatner NR, Khan MW, et al: The significant role of mast cells in cancer. Cancer Metastasis Rev 30: 45-60, 2011.
11. Huang B, Lei Z, Zhang GM, Li D, Song C, et al: SCF-mediated mast cell infiltration and activation exacerbate the inflammation and immunosuppression in tumor microenvironment. Blood 112: 1269-1279, 2008.
12. Ribatti D and Crivellato E: The controversial role of mast cells in tumor growth. Int Rev Cell Mol Biol 275: 89-131, 2009.
13. Wu K, Kryczek I, Chen L, Zou W and Welling TH: Kupffer cell suppression of CD8+ T cells in human hepatocellular carcinoma is mediated by B7-H1/programmed death-1 interactions. Cancer Res 69: 8067-8075, 2009.
14. Shen LS, Wang J, Shen DF, Yuan XL, Dong P, et al: CD4(+) CD25(+)CD127(low/-)regulatory T cells express Foxp3 and suppress effector T cell proliferation and contribute to gastric cancers progression. Clin Immunol 131: 109-118, 2009.
15. Kono K, Kawaida H, Takahashi A, Sugai H, Mimura K, et al: CD4(+)CD25high regulatory T cells increase with tumor stage in patients with gastric and esophageal cancers. Cancer Immunol Immunother 55: 1064-1071, 2006.
16. Ribatti D, Guidolin D, Marzullo A, et al: Mast cells and angiogenesis in gastric carcinoma. Int J Exp Pathol 91: 350-356, 2010.
17. Nielsen HJ, Hansen U, Christensen IJ, et al: Independent prognostic value of eosinophil and mast cell infiltration in colorectal cancer tissue. J Pathol 189: 487-495, 1999.
18. Ogino S, Shima K, Baba Y, Nosho K, Irahara N, et al: Colorectal cancer expression of peroxisome proliferator activated receptor ga m ma (PPA RG, PPA Rga m ma) is associated wit h good prognosis. Gastroenterology 136: 1242-1250, 2009.
19. Elpek GO, Gelen T, Aksoy NH, et al: The prognostic relevance of angiogenesis and mast cells in squamous cell carcinoma of the oesophagus. J Clin Pathol 54: 940-944, 2001.
20. Takanami I, Takeuchi K and Naruke M: Mast cell density is associated with angiogenesis and poor prognosis in pulmonary adenocarcinoma. Cancer 88: 2686-2692, 2000.
21. Molin D, Edström A, Glimelius I, et al: Mast cell infiltration correlates with poor prognosis in Hodgkin's lymphoma. Br J Haematol 119: 122-124, 2002.
22. Acikalin MF, Oner U, Topçu I, Yaşar B, Kiper H and Colak E: Tumour angiogenesis and mast cell density in the prognostic assessment of colorectal carcinomas. Dig Liver Dis 37: 162-169, 2005.
23. Stoyanov E, Uddin M, Mankuta D, et al: Mast cells and histamine enhance the proliferation of non-small cell lung cancer cells. Lung Cancer 75: 38-44, 2012.
24. Ju MJ, Qiu SJ, Gao Q, Fan J, Cai MY, et al: Combination of peritumoral mast cells and T-regulatory cells predicts prognosis of hepatocellular carcinoma. Cancer Sci 100: 1267-1274, 2009.
25. Lu LF, Lind EF, Gondek DC, et al: Mast cells are essential intermediaries in regulatory T-cell tolerance. Nature 31: 997-1002, 2006.
26. Eller K, Wolf D, Huber JM, et al: IL-9 production by regulatory T cells recruits mast cells that are essential for regulatory T cell-induced immune suppression. J Immunol 186: 83-91, 2011.
27. Yang Z, Zhang B, Li D, Lv M, Huang C, Shen GX and Huang B: Mast cells mobilize myeloid-derived suppressor cells and Treg cells in tumor microenvironment via IL-17 pathway in murine hepatocarcinoma model. PLoS One 5: e8922, 2010.
28. Kobayashi N, Hiraoka N, Yamagami W, Ojima H, Kanai Y, et al: FOXP3+ regulatory T cells affect the development and progression of hepatoca rcinogenesis. Clin Cancer Res 13: 902-911, 2007.
29. Griffiths RW, Elkord E, Gilham DE, Ramani V, Clarke N, Stern PL and Hawkins RE: Frequency of regulatory T cells in renal cell carcinoma patients and investigation of correlation with survival. Cancer Immunol Immunother 56: 1743-1753, 2007.
30. Ichihara F, Kono K, Takahashi A, Kawaida H, Sugai H and Fujii H: Increased populations of regulator y T cells in peripheral blood and tumor-infiltrating lymphocytes in patients with gast r ic a nd esophagea l ca ncers. Clin Ca ncer Res 9: 4404-4408, 2003.
31. Kawa ida H, Kono K, Ta ka hash i A, Suga i H, Mimu ra K, Miyagawa N, Omata H, Ooi A and Fujii H: Distribution of CD4+CD25high regulatory T-cells in tumor-draining lymph nodes in patients with gastric cancer. J Surg Res 124: 151-157, 2005.
32. Yuan XL, Chen L, Li MX, et al: Elevated expression of Foxp3 in tumor-infiltrating Treg cells suppresses T-cell proliferation and contributes to gastric cancer progression in a COX-2-dependent manner. Clin Immunol 134: 277-288, 2010
33. Yuan XL, Chen L, Zhang TT, et al: Gastric cancer cells induce human CD4+Foxp3+ regulatory T cells through the production of TGF-β1. World J Gastroenterol 17: 2019-2027, 2011.
34. Sayed BA, Christy A, Quirion MR and Brown MA: The master switch: the role of mast cells in autoimmunity and tolerance. Annu Rev Immunol 26: 705-739, 2008.